| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/08/1997 | EP0751778A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0663909B1 Method of obtaining 10-deacetylbaccatine iii |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139929A Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 01/08/1997 | CN1139925A 'Delta' 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/08/1997 | CN1033752C (1H-A201-1Ylmethyl) ubstituted quinoline, quinazoline or quinoxaline derivatives |
| 01/07/1997 | US5591851 Antiviral compounds |
| 01/07/1997 | US5591835 Substituted lactose derivatives |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591769 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | CA2079585C Ligand for the neu gene product |
| 01/03/1997 | WO1997000445A1 Process for producing gm2 specific antibodies |
| 01/03/1997 | WO1997000249A1 Heterocyclic compounds, their production and use |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000071A1 Androgenic directed compositions |
| 01/03/1997 | WO1996037621A3 Multimeric proteins |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | CA2225484A1 Androgenic directed compositions |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
| 01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
| 01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
| 01/02/1997 | EP0751144A1 Novel anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/02/1997 | EP0751125A1 Esters and amides of 9 (Z)-retinoic acid |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750640A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750633A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750612A1 Acridone-derived bisintercalators as chemotherapeutic agents |
| 01/02/1997 | EP0750609A1 Isoprenyl transferase inhibitors |
| 01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 01/02/1997 | EP0750514A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 01/02/1997 | EP0750497A1 Uses of perillyl alcohol and perillic acid methyl ester |
| 01/02/1997 | EP0750496A1 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
| 01/02/1997 | DE19523935A1 Pumpvorrichtung Pumping device |
| 01/01/1997 | CN1139455A Thrombin mutants |
| 01/01/1997 | CN1139430A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139380A Controlled release preparation |
| 01/01/1997 | CN1139116A Radioactive chitosan complex, its macroaggrgate and kit for preparing radioactive chitosan complex, process for preparation thereof, and use thereof for radiation therapy |
| 01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody |
| 01/01/1997 | CN1139003A Pulekang injection for curing cancer |
| 12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
| 12/31/1996 | US5589514 Arylcycloalkyl derivatives, their production and their use |
| 12/31/1996 | US5589509 Enhancing effect of administered tumor cell-locating porphyrins in light irradiation to destroy tumor cells |
| 12/31/1996 | US5589500 Substituted 1,1,2-triphenylbutenes and their use in the treatment of cancer |
| 12/31/1996 | US5589497 Antiandrogens |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589341 Origin of replication complex genes and methods of using the same |
| 12/31/1996 | US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof |
| 12/31/1996 | CA1338823C Platinum-polymer complexes and their use as antitumor agents |
| 12/28/1996 | CA2178684A1 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
| 12/27/1996 | WO1996035715A3 Pcna binding substance |
| 12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
| 12/27/1996 | EP0749981A1 Monoclonal antibody |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
| 12/27/1996 | EP0749487A1 Cell surface protein and effector cell bonding reagent |
| 12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
| 12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
| 12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 12/27/1996 | EP0749475A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 12/27/1996 | EP0749452A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 12/27/1996 | EP0749432A1 9-deoxotaxane compounds |
| 12/27/1996 | EP0749428A1 Isoxazoline compounds as inhibitors of tnf release |
| 12/27/1996 | EP0749425A1 New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| 12/27/1996 | EP0749422A1 Indole derivatives as cck receptor antagonists |
| 12/27/1996 | EP0749415A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 12/27/1996 | EP0749323A1 Methods for modulating t cell unresponsiveness |
| 12/27/1996 | EP0749318A1 Method of stimulating hematopoiesis with hemoglobin |
| 12/27/1996 | EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |